Genocea Biosciences, Inc. Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2006

Location

Cambridge MA US

Primary Industry

Biotechnology

Established

2006

Firm Ownership

Investment Team Staff

Total Staff

Request a demo to show more

Timeline of Key Events

Want to see the Timeline of Key Events?

Request a demo for full access to this profile.

Financials

Fiscal Year Ended
Revenue (USD)
% Revenue Growth (YoY)
Operating Income (USD)
Operating Margin
EBITDA (USD)
% EBITDA Margin
NET Income (USD)
% Net Margin

31 Dec 2013

731,000

(19,925,000)

(2725.7%)

(19,607,000)

(2682.2%)

(20,806,000)

(2846.2%)

31 Dec 2014

308,000

(57.9%)

(33,166,000)

(10768.2%)

(32,671,000)

(10607.5%)

(35,296,000)

(11459.7%)

31 Dec 2015

670,000

117.5%

(41,366,000)

(6174%)

(40,315,000)

(6017.2%)

(42,483,000)

(6340.7%)

31 Dec 2016

235,000

(64.9%)

(48,245,000)

(20529.8%)

(46,432,000)

(19758.3%)

(49,573,000)

(21094.9%)

31 Dec 2017

(100%)

(55,255,000)

(53,739,000)

(56,710,000)

31 Dec 2018

(39,518,000)

(38,430,000)

(27,811,000)

31 Dec 2019

31 Dec 2020

31 Dec 2021

Unlock the recent years of financials and more for Genocea Biosciences, Inc..

Request a demo to see more.

Key Contacts

Name	Position	Start Date	End Date	Vcard	Bio
	Board of Directors						BM

BM Board Member

Name	Firm	Deal Date	Number Of Deals	Vcard
						AI LP
						AI LP

AI Active Investor LP Lead Provider

Want to see more?

Request a demo for full access to this profile.

Employee Data

Want to see the Employee Count?

Request a demo for full access to this profile.

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.